CHIRALIS Trademark

Trademark Overview

On Thursday, November 21, 2024, a trademark application was filed for CHIRALIS with the United States Patent and Trademark Office. The USPTO has given the CHIRALIS trademark a serial number of 98865594. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, May 21, 2025. This trademark is owned by CMS Biotechnologies, Inc.. The CHIRALIS trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Manufacturing of enantiopure pharmaceuticals and chemicals for the purpose of reducing human side effects of compounds sold
chiralis

General Information

Serial Number98865594
Word MarkCHIRALIS
Filing DateThursday, November 21, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateWednesday, May 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesManufacturing of enantiopure pharmaceuticals and chemicals for the purpose of reducing human side effects of compounds sold

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code040
First Use Anywhere DateSunday, June 30, 2024
First Use In Commerce DateSunday, June 30, 2024

Trademark Owner History

Party NameCMS Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBellmore, NY 11710

Trademark Events

Event DateEvent Description
Thursday, November 21, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 14, 2025ASSIGNED TO EXAMINER
Wednesday, May 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

chiralis side effects compounds sold human reducing enantiopure pharmaceuticals chemicals purpose